We subsequently analyzed the kinase-type PCC patient, and identified the activation of FGF signaling network (Figure 6H) and major involvement of FGF1-FGFR1 in the FGF pathway (Figure 6I). The gene discussed is FGFR1; the disease is adrenal gland pheochromocytoma.